Details

---

Manufacturer
PATHEON INC.(CANADA)
Registraction Number
MAL24086002ACRZ

Contents

Active Ingredient: Deucravacitinib, 6 mg per tablet.
Excipients: Includes lactose monohydrate and other inactive ingredients.

Indications

Sotyktu is used for:
Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
It works by selectively inhibiting tyrosine kinase 2 (TYK2), reducing inflammation associated with psoriasis.

Instructions

Dosage: The recommended dose is 6 mg taken orally once daily.
Administration: Take with or without food. Swallow the tablet whole; do not crush, cut, or chew.
Precautions:
Avoid use if allergic to deucravacitinib or other ingredients.
Regular monitoring is recommended for infections, liver function, and other health conditions.
Consult a doctor if pregnant, breastfeeding, or taking other medications.
Storage: Store below 30°C and protect from light.